Tuesday, April 25
11:15 am - 3:45 pm

Registration Open

11:15 am - 12:00 pm

Networking Lunch

12:00 pm - 12:15 pm


JC Scott, President & Chief Executive Officer, PCMA

Ian Spatz, National Advisor, Manatt, Phelps & Phillips

12:15 pm - 12:45 pm

Capitol Hill Perspectives on Proposals to Address Drug Costs – Closed to Media

Katie McInnis, Chief Counsel, House Subcommittee on Administrative State, Regulatory Reform, and Antitrust

Franci Rooney, Counsel, Senator John Cornyn, Senate Judiciary Committee

12:45 pm - 1:10 pm

Competition and Client Choices in the PBM Marketplace

James Gartner, President, PerformRx


1:10 pm - 1:35 pm

IRA Update: Implementation and Public Engagement

Meena Seshamani, MD, PhD, Deputy Administrator and Director, Center for Medicare


1:35 pm - 2:00 pm

How PBMs are Addressing Rising Healthcare Costs

William Fleming, President, Pharmacy Solutions and Chief Corporate Affairs Officer, Humana

2:00 pm - 2:25 pm

How PBMs Support Providers and Patients and the Point of Prescribing

Lisa Smith, Chief of Operations, Optum Rx


2:25 pm - 2:50 pm

Using Evidence to Achieve Prescription Drug Access and Affordability

Sarah K. Emond, MPP, Executive Vice President and Chief Operating Officer, Institute for Clinical and Economic Review (ICER)


2:50 pm - 3:15 pm

Beyond Price Negotiations: How PBM Clinical Programs Work to Optimize Patient Outcomes

Christine Gilroy, Chief Medical Officer, Express Scripts


3:15 pm - 3:45 pm

Reactions and Thoughts on Current Proposals to Lower Drug Costs and Improve Competition

Scott Gottlieb, M.D., Former United States Commissioner, U.S. Food & Drug Administration